MiGo Tracker Remote Monitoring of Home Exercise After Stroke

Condition(s) studied

Investigational drug(s) / intervention(s)

MiGo Tracker: Perform home exercise sessions while wearing MiGo Tracker device that logs exercise data.

Conventional home exercise program: Exercise following printed sheets or booklet

Study summary

This project will determine the safety and effectiveness of a MiGo Tracker RTM program in a randomized controlled trial with individuals with subacute stroke (N=50). Participants will be randomly assigned to either the MiGo Tracker RTM program (intervention group) or prescription of home exercises with no monitoring (usual care/control group). All participants will still receive usual post-stroke care, including outpatient rehabilitation. The main question this study aims to answer is: Does a MiGo Tracker RTM program lead to significantly greater motor recovery at three-months post stroke than the usual care group. If successful, MiGo Tracker will lead to increased home exercise adherence and improved health outcomes for thousands of individuals following stroke.

Eligibility

Primary outcome measure(s)

• Change in Upper Extremity Fugl-Meyer from Baseline — Baseline and 3 months post stroke
  The Fugl-Meyer Assessment - Upper Extremity (FMA-UE) is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, sensation, balance, joint range of motion and joint pain in patients with post-stroke hemiplegia. A standardized assessment of arm impairment based on scores of 0-2 on 33 different tasks. Minimum value = 0, maximum value = 66, higher scores = better outcome

Trial sites (1)